Why the study?
Do pharmacologic probes that block the renin-angiotensin system reduce blood pressure in relation to baseline plasma renin levels in hypertensive patients?
Do pharmacologic probes that block the renin-angiotensin system reduce blood pressure in relation to baseline plasma renin levels in hypertensive patients?
This historical review outlines the foundational research demonstrating that the renin-angiotensin-aldosterone system drives malignant and essential hypertension, establishing the mechanistic basis for the antihypertensive efficacy of beta-blockers, ACE inhibitors, and ARBs.
No takes yet. Share an insight, caveat, or question.
May inform renin-based antihypertensive selection; leaves open prospective validation in contemporary cohorts.
J Laragh (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: